PREVENT Pandemics Act

Summary

Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or the PREVENT Pandemics Act This bill sets out programs and activities primarily to address public health preparedness and response. Specifically, the bill establishes a legislative task force to investigate the COVID-19 pandemic and a White House office to advise on pandemic preparedness and response. It also revises authorities, programs, and other aspects of the Department of Health and Human Services and associated agencies to support preparedness and response activities at all levels of government. Other matters addressed in the bill include grants related to health disparities and for centers for public health preparedness; collection and dissemination of public health data (e.g., genomic sequencing of pathogens); workforce programs for public health and related fields; the safety and availability of the blood supply; research concerning viruses and other pathogens with pandemic potential, vaccines and other medical countermeasures, and the long-term health effects of COVID-19; biosafety and security related to biological agents and toxins; national security, privacy and information security, and foreign influence in biomedical research; the administration of the Strategic National Stockpile; and domestic manufacturing of medical countermeasures. The bill also modifies the regulation of medical products with a particular focus on expediting the development and approval of medical countermeasures. Additional areas of focus include strengthening medical product supply chains and supporting innovation in, for example, clinical trial designs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 10 March 2022

   Introduced

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

   Source: IntroReferral

2. 10 March 2022

   Introduced

   Introduced in Senate

   Source: IntroReferral

3. 15 March 2022

   Reported

   Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 10 March 2022 · Download file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 10 March 2022

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 10 March 2022

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in Senate

  summary · EN · 10 March 2022

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Sen. Murray, Patty [D-WA] · D · Sponsor
• Sen. Burr, Richard [R-NC] · R · Sponsor
• · sshr00 · Standing

Related records

• related to → Fix Nondisclosure of Influence in Health Research Act
• related to → Protecting the Integrity of our Biomedical Research Act of 2021
• related to → Protect America’s Biomedical Research Enterprise Act of 2021
• related to → To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection.
• related to → Emergency Use Transparency Act
• related to → Registration of Certain Foreign Establishments Act
• related to → Promoting ACCESS to Diagnostics Act
• related to → Improving Trauma Systems and Emergency Care Act
• related to ← Tracking Pathogens Act
• related to ← Drug Shortages Shelf Life Extension Act
• related to ← Building a Sustainable Workforce for Healthy Communities Act
• related to ← Improving Trauma Systems and Emergency Care Act
• related to ← Improving DATA in Public Health Act
• related to ← National Task Force on the COVID-19 Pandemic Act

Showing 14 of 28 related records.